IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,376,814 | -11.3% | 558,340 | -2.0% | 0.01% | -11.1% |
| Q2 2023 | $6,060,767 | +4.0% | 569,621 | +2.9% | 0.01% | -10.0% |
| Q1 2023 | $5,825,723 | +143.1% | 553,776 | +186.3% | 0.01% | +150.0% |
| Q4 2022 | $2,396,660 | +1.0% | 193,435 | -15.6% | 0.00% | 0.0% |
| Q3 2022 | $2,374,000 | -8.6% | 229,184 | +1.7% | 0.00% | -20.0% |
| Q2 2022 | $2,597,000 | +150.7% | 225,306 | +173.5% | 0.01% | +150.0% |
| Q1 2022 | $1,036,000 | -79.6% | 82,367 | -75.0% | 0.00% | -90.0% |
| Q1 2018 | $5,076,000 | – | 328,993 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |